Xenetic Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview

Xenetic Biosciences

17/03/2025 20:02

Xenetic Biosciences Inc XBIO.OQ XBIO.O is expected to show a fall in quarterly revenue when it reports  results on March 19 (estimated) for the period ending December 31 2024

The Framingham Massachusetts-based  company is expected to report a 65.8% decrease in revenue to $230 thousand from $672 thousand a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Xenetic Biosciences Inc is for a loss of 20 cents per share.

The one available analyst rating on the shares is "hold".

The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated March 17 at 20:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)